Choline salicylate 293 mg / magnesium salicylate 362 mg Oral Tablet [Trilisate]
RxNorm 201117
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 201117 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: choline salicylate 293 mg / magnesium salicylate 362 mg Oral Tablet [Trilisate].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Choline salicylate 293 mg / magnesium salicylate 362 mg Oral Tablet [Trilisate]
(Atom ID: 12364453)
SY